| Breakdown | TTM | Sep 2025 | Sep 2024 | Sep 2023 | Sep 2022 | Sep 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 79.70B | 78.91B | 75.93B | 74.88B | 71.98B | 62.27B |
| Gross Profit | 30.94B | 30.40B | 29.82B | 29.12B | 25.85B | 22.74B |
| EBITDA | 15.31B | 15.86B | 15.34B | 15.11B | 13.48B | 11.64B |
| Net Income | 7.95B | 9.62B | 8.30B | 7.95B | 3.72B | 5.26B |
Balance Sheet | ||||||
| Total Assets | 170.13B | 166.20B | 147.81B | 145.07B | 151.50B | 139.61B |
| Cash, Cash Equivalents and Short-Term Investments | 15.26B | 15.52B | 10.22B | 11.13B | 11.70B | 10.68B |
| Total Debt | 56.47B | 56.01B | 47.92B | 46.60B | 50.64B | 48.70B |
| Total Liabilities | 98.11B | 97.83B | 91.58B | 92.01B | 96.70B | 90.33B |
| Stockholders Equity | 65.48B | 62.24B | 51.26B | 47.79B | 48.90B | 44.37B |
Cash Flow | ||||||
| Free Cash Flow | 8.96B | 9.08B | 9.58B | 10.09B | 8.16B | 8.27B |
| Operating Cash Flow | 11.40B | 11.52B | 11.66B | 12.24B | 10.24B | 10.00B |
| Investing Cash Flow | -14.38B | -11.31B | -3.28B | -3.18B | -2.49B | -15.49B |
| Financing Cash Flow | 5.00B | 5.37B | -8.88B | -8.73B | -7.50B | 785.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
76 Outperform | €10.64B | 25.10 | 25.25% | ― | 3.49% | 3003.48% | |
72 Outperform | €159.84B | 38.10 | 18.13% | ― | 11.33% | ― | |
71 Outperform | €9.85B | 22.78 | 17.54% | 2.01% | 1.35% | 10.41% | |
66 Neutral | €1.73B | 11.99 | 0.33% | 2.76% | 2.34% | 19.31% | |
65 Neutral | €185.31B | 22.98 | 12.93% | 2.18% | 3.20% | -16.91% | |
56 Neutral | €1.48B | 7.78 | -3.19% | 3.12% | -2.86% | 101.14% | |
55 Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% |